Blog
RSS FeedPosted by Michael Wonder on 03 Jul 2025
Bayer's Adempas gets insurance coverage in Korea 11 years after approval
21 May 2025 - The pulmonary arterial hypertension medicine Adempas (riociguat) will be covered by national health insurance starting next ...
Posted by Michael Wonder on 02 Jul 2025
Life-saving breast cancer drug now cheaper thanks to expansion of the PBS
1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...
Posted by Michael Wonder on 01 Jul 2025
New Zealand Pharmaceutical Schedule - 1 July 2025
1 July 2025 - The July 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Jul 2025
Schedule of Pharmaceutical Benefits - 1 July 2025
1 July 2025 - The July 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 10 Jun 2025
Research funding and more treatment options to support the fight against MND
9 June 2025 - The Australian Government is providing a further $4.5 million and listing another treatment to ensure the ...
Posted by Michael Wonder on 01 Jun 2025
Schedule of Pharmaceutical Benefits - 1 June 2025
1 June 2025 - The June 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 04 May 2025
Government lists life-changing epilepsy drug fenfluramine on PBS
4 May 2025 - For the Sutton family, finding a drug that controlled four-year-old daughter Layla’s rare form of epilepsy was ...
Posted by Michael Wonder on 27 Apr 2025
Ketamine nasal spray to become cheaper for Australians with treatment-resistant depression
28 April 2025 - A nasal spray that uses a form of ketamine to treat stubborn depression will be added ...
Posted by Michael Wonder on 11 Apr 2025
13,000 people to benefit from new insulin medicine
11 April 2025 - Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from ...
Posted by Michael Wonder on 10 Apr 2025
Pfizer wins Korea nod for paediatric arthritis use of oral JAK inhibitor Xeljanz
7 April 2025 - Pfizer Korea has won national reimbursement for its oral JAK inhibitor Xeljanz (tofacitinib), expanding access to ...
Posted by Michael Wonder on 10 Apr 2025
PHARMAC to fund medicines for blood cancers, inflammatory bowel disease, eczema and arthritis
10 April 2025 - More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, ...
Posted by Michael Wonder on 03 Apr 2025
GSK Korea's long-acting HIV injection therapy gains insurance benefit
1 April 2025 - GSK Korea said its long-acting injectable HIV-1 combination treatment, Vocabria (cabotegravir 600 mg) and Rekambys (rilpivirine ...
Posted by Michael Wonder on 27 Mar 2025
New and expanded cheaper medicines
27 March 2025 - Australians with Cushing’s syndrome, retinal vein occlusion and psoriatic arthritis, leukaemia, and women needing contraception and menopause ...
Posted by Michael Wonder on 17 Mar 2025
Government delivering even more choice for women's contraception, endometriosis, and IVF journeys
16 March 2025 - The Government is delivering even more choice for Australian women with new and amended listings for contraception, ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...